Related Experiment Video
Updated: Jul 16, 2026
05:39
A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
Can directed activity improve mobility in Huntington's disease?
1Cardiff University, School of Health Care Studies, Department of Physiotherapy, Ty Dewi Sant, Heath Park, UK. rossera2@cf.ac.uk
Brain Research Bulletin
|March 14, 2007
Summary
Huntington's disease (HD) is a progressive neurodegenerative disorder. More research is needed on rehabilitation strategies to improve mobility, cognition, and behavior in HD patients.
Area of Science:
- Neuroscience
- Genetics
- Rehabilitation Medicine
Background:
- Huntington's disease (HD) is an inherited central nervous system (CNS) disorder.
- HD causes progressive decline in mobility, cognition, and behavior.
- Currently, no disease-modifying treatments exist for HD.
Purpose of the Study:
- To highlight the need for systematic studies on rehabilitation approaches for Huntington's disease.
- To emphasize the importance of objective assessment tools in evaluating rehabilitation efficacy.
- To explore the potential role of rehabilitation and training in conjunction with novel therapeutic options.
Main Methods:
- Literature review and analysis of existing research on Huntington's disease interventions.
- Identification of research gaps in the area of rehabilitation for HD.
- Discussion of the necessity for standardized assessment tools.
Main Results:
- Limited research exists on the efficacy of rehabilitation strategies for HD.
- There is a lack of objective assessment tools to measure the impact of interventions.
- Rehabilitation may play a crucial role alongside emerging treatments.
Conclusions:
- Systematic investigation of rehabilitation approaches is essential for managing HD symptoms.
- Development of robust assessment tools is critical for tracking patient progress.
- Integrating rehabilitation with novel therapies holds promise for improving patient outcomes in HD.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...